Further, we show that in the ELSA cohort, primary statin therapy is associated with reduced incidence of cardiovascular disease in individuals with CHIP compared to controls, suggesting that statins may have a more specific action in CHIP than the general population. Here, STUB1 is linked to cardiovascular disorder.